- Home
- MRVI vs CYRX Comparison
MRVI vs CYRX Comparison
Compare MRVI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- CYRX
- Stock Information
- Founded
- MRVI 2014
- CYRX 1999
- Country
- MRVI United States
- CYRX United States
- Employees
- MRVI N/A
- CYRX N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- MRVI Health Care
- CYRX Health Care
- Exchange
- MRVI Nasdaq
- CYRX Nasdaq
- Market Cap
- MRVI 371.8M
- CYRX 438.7M
- IPO Year
- MRVI 2020
- CYRX N/A
- Fundamental
- Price
- MRVI $2.42
- CYRX $8.86
- Analyst Decision
- MRVI Hold
- CYRX Strong Buy
- Analyst Count
- MRVI 10
- CYRX 10
- Target Price
- MRVI $5.84
- CYRX $11.70
- AVG Volume (30 Days)
- MRVI 1.4M
- CYRX 1.1M
- Earning Date
- MRVI 08-11-2025
- CYRX 08-05-2025
- Dividend Yield
- MRVI N/A
- CYRX N/A
- EPS Growth
- MRVI N/A
- CYRX N/A
- EPS
- MRVI N/A
- CYRX 1.35
- Revenue
- MRVI $219,830,000.00
- CYRX $237,879,000.00
- Revenue This Year
- MRVI N/A
- CYRX N/A
- Revenue Next Year
- MRVI $7.23
- CYRX $9.08
- P/E Ratio
- MRVI N/A
- CYRX $6.49
- Revenue Growth
- MRVI N/A
- CYRX 24.93
- 52 Week Low
- MRVI $1.67
- CYRX $4.58
- 52 Week High
- MRVI $9.60
- CYRX $9.48
- Technical
- Relative Strength Index (RSI)
- MRVI 49.60
- CYRX 58.38
- Support Level
- MRVI $2.28
- CYRX $8.57
- Resistance Level
- MRVI $2.47
- CYRX $8.99
- Average True Range (ATR)
- MRVI 0.14
- CYRX 0.47
- MACD
- MRVI -0.01
- CYRX -0.02
- Stochastic Oscillator
- MRVI 27.45
- CYRX 71.34
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.